alexa Molecular Diagnostics in Melanocytic Tumors: The Pathologists Perspective | OMICS International | Abstract
ISSN: 2572-5645

Advances in Molecular Diagnostics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Opinion Article

Molecular Diagnostics in Melanocytic Tumors: The Pathologists Perspective

Gerardo Ferrara1* and Giuseppina Improta2

1Department of Oncology, Anatomic Pathology Unit, Geatano Rummo General Hospital, Benevento, Italy

2Laboratory of Clinical Research and Advanced Diagnostics, IRCCS-CROB Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture, Italy

*Corresponding Author:
Gerardo Ferrara
Department of Oncology
Anatomic Pathology Unit
Geatano Rummo General Hospital
Benevento, Italy
Tel: 39082457315
E-mail: [email protected]

Received: January 27, 2016; Accepted: January 29, 2016; Published: February 01, 2016

Citation: Ferrara G, Improta G (2016) Molecular Diagnostics in Melanocytic Tumors: The Pathologist’s Perspective. Adv Mol Diag 1:102.

Copyright: © 2016 Ferrara G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

During the last 15 years, molecular techniques have led to a fast gain in our knowledge on the development of melanocytic tumors. The potential implications of these advances for prognosis and therapy of melanoma patients are outstanding. There is, however, an even greater problem which has to be raised: since the histopathological diagnosis of melanoma is matter of considerable disagreement even among experts [1]. Pathologists have been increasingly asking for a molecular ‘key to the code’ in order to overcome the diagnostic limitations of conventional morphology. Table 1 summarizes the main molecular techniques and their expected results in melanoma [2], are these data meaningful also for the histopathological differential diagnosis between ‘nevus’ and ‘melanoma’?

Keywords

Leave Your Message 24x7
Top